Welcome to Active Biotech’s virtual capital markets day. You will get updates on our new direction, our clinical strategy and our project milestones.

Enjoy our presentations and feel free to send us questions to be answered at the live event at 14.00 CET.

Novel immunomodulatory treatments for patients with cancer or inflammatory diseases

Active Biotech focuses on the research and development of pharmaceuticals in therapeutic areas in which the immune system is of central importance. The project portfolio comprises therapy developed for the treatment of cancer and inflammatory diseases.

Diseases where the immune system is of central importance